Inside one of the new production facilities the China National Biotec Group (CNBG) has built for manufacturing a Covid-19 vaccines CNBG announced that one of the potential vaccine candidates had completed phase one and phase two clinical trials. Photo: The State-owned Assets Supervision and Administration Commission